A common consequence of taking GLP-1 receptor agonists is losing interest in alcohol.

Now, I agree that’s not the only factor — there’s something else going on reducing alcohol consumption even in people who’ve never taken GLP-1RAs — but when you have >10% of the population taking them, that’s another significant factor contributing to falling drinking rates.